"Health & Medical News"

Depressed medical residents make six times more medication errors than residents who are not depressed, according to a U.S. study published online Feb. 7 in the British Medical Journal.

“Depression is a significant problem for residents as well as for their patients,” said lead study author Amy Fahrenkopf, MD, MPH. “The fact that it’s a problem for both needs to be addressed.”

Read the rest of this entry »

Popularity: unranked [?]

As big-name national retailers and pharmacy chains continue to open in-store clinics, a familiar face soon may enter the fray as well — your local hospital.

Wal-Mart recently announced plans to partner with community hospitals across the country to open up 400 new retail clinics inside its stores by 2010, in addition to the 55 it already houses. Thirteen of those are owned and operated by hospital systems.

Read the rest of this entry »

Popularity: unranked [?]

If you’re new here, you may want to subscribe to my RSS feed.Thanks for visiting!

BBC News Online’s health team examines the issues surrounding alternative medicine as research shows Many doctors dismiss alternative medicine as unproven, ineffective and

SignOnSanDiego.com > Read the rest of this entry »

Popularity: unranked [?]

If you’re new here, you may want to subscribe to my RSS feed.Thanks for visiting!

Intel to Create Technologies for Elderly Health in Ireland A Virtual Desktops Case Study with Joel Shore. You have a choice!Ericom’s Alternative to Citrix

Education Ireland - Primary Education
Read the rest of this entry »

Popularity: unranked [?]

An economic hardship student loan deferment program that medical school graduates use as they go through residency will remain in place until fall of 2008, and more students are eligible to participate.

The U.S. Dept. of Education announced Nov. 1 that it will temporarily reinstate the program, with a final decision on its fate due next year.

Read the rest of this entry »

Popularity: unranked [?]

An anti-psychotic drug already approved in the U.S. to treat adults and adolescents with schizophrenia may soon be available for youngsters age 10 to 17 years of age suffering from bipolar disorder.

The U.S. Food and Drug Administration (FDA) has given priority review status to the drug Abilify which is manufactured by Bristol-Myers Squibb and Otsuka Pharmaceutical.

Read the rest of this entry »

Popularity: unranked [?]